Home / Nervous system / Buspirone
ATC N05BE01 · Azaspirodecanedione Derivatives
Buspirone shortage
As of 2 Nov 2026, Buspirone has a reported shortage in 1 of the 16 countries we track (Canada), covering 2 products from 2 companies.
Countries1/16
Products2packs or presentations
Companies20 listed
Short since23 Jan 20242.8 years ago
Earliest returnnot givencompany estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada2 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage
Timeline
Canada
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-BUSPIRONE (100 BTL) | APOTEX INC | 23 Jan 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | BUSPIRONE (100) | SANIS HEALTH INC | 17 Dec 2025 | not given | Other Other (Please describe in comments) |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.